Lung cancer

5 currently open clinical trials
Durvalumab in patients with advanced lung cancer and poor general state of health
SAKK 19/17
A multicentre randomised phase III trial comparing atezolizumab plus bevacizumab and standard chemotherapy versus bevacizumab and standard chemotherapy as first-line treatment in advanced malignant pleural mesothelioma
ETOP BEAT-meso
Adjuvant immunotherapy for limited-stage small cell lung cancer
ACHILES
Immunotherapy and radiotherapy in stage III non-small cell lung cancer
SAKK 16/18
Treatment of advanced non-small cell lung cancer or of mesothelioma with gemcitabine and atezolizumab
SAKK 17/18
All cancer types